TP53 and cancer: This study suggests that the different proteoforms of p53 and p63 could not only contain cryptic epitopes as p73 proteoforms -as 3D-models suggested (Figure 2), but might also produce a differential seroreactivity able to improve the diagnostic effectiveness of these cancer autoantigens [32].